Search the Newsreel

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …

Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET)

Adicet Bio presents a differentiated allogeneic gamma delta CAR-T platform targeting autoimmune diseases, trading below cash value with a pivotal readout for prula-cel in lupus nephritis imminent in Q3 2026. Early data showed a 50% complete renal response and a clean safety profile. The …

(PRAX) and the Role of Price-Sensitive Allocations

This article provides a detailed AI-driven analysis of Praxis Precision Medicines Inc. (NASDAQ: PRAX), highlighting a strong overweight bias across all time horizons. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report …

TransMedics Group, Inc. Investor News: Rosen Law Firm

The Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). The firm is encouraging shareholders of TransMedics Group to visit its website or contact them for more information regarding …

Brandes Investment Partners reports 14.9% Utah Medical Products (UTMD) stake

DYAI: Second Quarter Results

Die Becton-Dickinson-Aktie profitiert von Gewinnanstieg und erhöhter Prognose

Medicenna Therapeutics Corp. Reports Earnings Results for the First Quarter Ended June 30, 2026

Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez

Dyadic International (DYAI) reportó ingresos estables en el segundo trimestre de 2026 de $961,000, con una pérdida neta que aumentó a $2.1 millones, y sus ingresos del primer semestre crecieron un 52% a $2.1 millones. A pesar de los progresos comerciales, la empresa finalizó …

Credicorp Q2 Earnings Call Highlights

Key Points Interested in Credicorp Ltd.? Here are five stocks we like better. Credicorp delivered strong profitability, with second-quarter ROE of 20.3%, improved asset quality and a 13.1% year-over-year increase in loans. Management raised its medium-term ROE expectation to approximately 22%. The company raised …

Earnings call transcript: Credicorp tops Q2 2026 estimates as ROE rises

Credicorp reported strong Q2 2026 results, exceeding Wall Street expectations for profit and revenue, and raising its medium-term return-on-equity target to 22%. The Peru-based financial group saw robust loan growth, improved asset quality, and strong performance across its banking, insurance, and asset-management businesses, despite …

Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy?

Alpha Tau Medical (DRTS) reported a significant widening of its net loss to US$68.75 million in the first half of 2026, up from US$18.81 million a year prior, leading to increased concerns about its funding risk. Despite the company's focus on clinical progress for …

Nordic American Tankers (NYSE:NAT) Sets New 12-Month High - Here's Why

Nordic American Tankers (NYSE:NAT) reached a new 52-week high of $6.81, despite a "Reduce" consensus rating and an average price target of $4.00 from analysts. The company reported quarterly EPS of $0.17, beating estimates, and increased its quarterly dividend to $0.22 per share, resulting …

Solas Capital discloses 9.99% Modular Medical (MODD) position via stock and warrants

Solas Capital Management, LLC and Frederick Tucker Golden have reported an amended beneficial ownership of 9.99% in Modular Medical, Inc. (MODD). This stake comprises 552,171 shares, including common stock and shares issuable upon warrant exercise, with shared voting and dispositive power. The filing details …

Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance

Shanghai HeartCare Plans A Share Issue and Sci-Tech Board Listing

ICU Medical (ICUI) Insider Sells 5,417 Shares: VP, GM-Infusion Capital Daniel Woolson Reduces Stake

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …

Fischer Medical Ventures Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Sell Alert: Daniel Woolson Cashes Out $982K In ICU Medical Stock

Daniel Woolson, VP at ICU Medical (NASDAQ: ICUI), recently sold 5,417 shares of the company's stock for a total transaction value of $982,264, as disclosed in an SEC filing. This insider transaction occurred on August 13, leading to a slight dip in ICU Medical's …

Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake

Armistice Capital, LLC and Steven Boyd have reported an updated beneficial ownership stake of 8.01% in Orthofix Medical Inc., totaling 3,264,000 shares. This disclosure, made via an Amendment No. 8 to their Schedule 13G, indicates shared voting and dispositive power over these shares, which …

Mobia Medical, Inc. - Common Stock MOBI

Mobia Medical, Inc. (NASDAQ:MOBI) reported strong second-quarter results with revenue reaching $13.5 million, marking a 102% increase year-over-year. This growth is attributed to the expanded adoption of its Vivistim paired vagus nerve stimulation therapy within stroke-care programs.

Armistice Capital reports 9.99% ownership of Tenon Medical (TNON) through Master Fund

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Tenon Medical, Inc. (TNON) through Armistice Capital Master Fund Ltd. This ownership, totaling 54,554 shares, grants them shared voting and dispositive power. The filing specifies that the Master Fund retains …

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power

Woodline Partners LP has reported a beneficial ownership of 8.1% in CalciMedica, Inc., totaling 2,489,729 shares of common stock. The investment firm, acting as an adviser to Woodline Master Fund LP, holds sole voting and dispositive power over these shares. This disclosure, made via …

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership stake of 6,364,000 shares in Treace Medical Concepts, Inc. (TMCI), representing 9.79% of the outstanding common stock. This ownership is held directly by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 300,332 ordinary shares of IceCure Medical Ltd. (ICCM), representing 9.99% of the class, through a Schedule 13G SEC filing. These shares are held with shared voting and dispositive power. Armistice Capital acts as …

Why Medicenna Therapeutics Corp stock is skyrocketing today

T. Rowe Price Associates (KMTS) discloses 4.97M Kestra Medical shares in 13G/A

T. Rowe Price Associates, Inc. has disclosed a beneficial ownership of 4,968,900 shares of Kestra Medical Technologies common stock, representing 8.5% of the class as of June 30, 2026. The firm holds sole voting power over 4,966,936 shares and sole dispositive power over all …

Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance

Fresenius Medical Care stock is trading steadily around $23 in mid-August 2026, influenced by recent share buybacks and a modest year-to-date decline. The company's capital allocation strategy now includes renewed willingness for buybacks, alongside guidance for continued mid-single-digit revenue growth and improved operating income …

Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica

Armistice Capital, LLC and Steven Boyd have reported a significant holding in CalciMedica, Inc., disclosing beneficial ownership of 3,411,361 shares, which represents 9.99% of the company's common stock. The shares are directly held by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …

Nordic American Tankers stock hits 52-week high at 6.76 USD

Nordic American Tankers Ltd (NAT) has reached a 52-week high of $6.76, demonstrating a remarkable 1-year return of 169% and a year-to-date gain exceeding 106%. The company's market capitalization is $1.43 billion, and it offers an attractive 13.3% dividend yield, consistently paying dividends for …

New Ray Medicine Sets August Board Meeting to Review Interim Results and Dividend

SBC Medical Group's (SBC) Buy Rating Reiterated at BTIG Research

BTIG Research has reiterated its "Buy" rating for SBC Medical Group (NASDAQ: SBC) and set an $8.00 price target, representing a potential 150.78% upside. Despite this, analyst sentiment is mixed with an average "Hold" rating and an $8.50 target price from multiple analysts. The …

Credicorp Ltd. Stock 12‑Month Price Target Raised to $436.51, Implies 16% Upside

Analysts have raised the 12-month average price target for Credicorp Ltd. stock to $436.51 from $433.39, implying a 16% potential upside from its August 13 closing price. The consensus rating from 13 analysts remains a "Buy," with 10 Buys and 3 Holds. This updated …

Medicamen Biotech Q1 Results: Net profit up 54% YoY to ₹252.69 lakh

Tian An Medicare Limited Reports Earnings Results for the Half Year Ended June 30, 2026